Functional Remediation for Bipolar Disorder

Bipolar Disorder Clinical Trial

Official title:

A Pilot Study of Functional Remediation for Bipolar Disorder: Feasibility and Preliminary Efficacy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03403179
• Other study ID #: HUM00113668
• Status: Completed
• Phase: N/A
• Start date: November 17, 2017
• Est. completion date: December 20, 2018

Study information

• Verified date: February 2019
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 20, 2018
• Est. primary completion date: December 10, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• diagnosis of bipolar I or II disorder (BD), as determined by a structured diagnostic interview

• at least three months of clinical remission (euthymia or minimal symptoms), based on the phone screen assessing mood episodes in the prior three months

• score greater than 11 on a measure of everyday functioning (FAST; described in measures section) indicating at least mild impairment

• use of a standard bipolar mood-stabilizing medication at the same, adequate dose (according to CANMAT treatment guidelines) for at least 3 months prior to screening, with ability to continue that dose during the study.

Exclusion Criteria:

• history of neurological illness or injury (e.g., stroke, brain tumor)

• documented intellectual disability

• inability to provide written informed consent

• substance dependence within last 3 months or substance abuse in last 30 days

• inability to complete the six-month intervention

• received ECT in the past 12 months

Related Conditions & MeSH terms

• Bipolar Disorder
• Disease

Intervention

Other:
• Functional Remediation
Functional Remediation: The functional remediation program consists of 21 weekly sessions, each lasting 90 min. This intervention addresses neurocognitive issues such as attention, memory and executive functions, but it focuses even more on enhancing functioning in daily routine. The content of the intervention is based on ecological tasks to be performed in two settings, in the clinic as well as at home. Participants will be trained with exercises for memory, attention, problem solving and reasoning, multitasking and organization in order to improve their functional outcome. Most of the techniques are based on paper-and-pencil tasks and group activities.

Locations

Country	Name	City	State
United States	University of Michigan Depression Center	Ann Arbor	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility	Feasibility will be determined by a composite of ability to recruit and deliver the treatment intervention to both cohorts of participants, with adequate delivery of the intervention as measured by completion of the manual's objectives.	30 weeks
Primary	Acceptability (Subject Satisfaction)	Acceptability of the intervention will be measured by use of the Satisfaction with Therapy and Therapist Scale.	30 weeks
Primary	Acceptability (Subject completion)	Measured by percentage of subjects who complete the intervention.	30 weeks
Secondary	Functional Impact	The Functioning Assessment Short Test (FAST) is an interviewer-administered scale for disability due to psychiatric illness, used both pre-and post-completion. The instrument has 24 items capturing 6 domains of functioning: (1) Autonomy (2) Occupational Functioning (3) Cognitive Functioning (4) Financial Issues (5) Relationships (6) Leisure Time. Scores above 11 identify at least mild functional impairment. Impact of the intervention on change in FAST score will be examined.	30 weeks